  | Today's Top Story |  |  | |  | Earn 2X rewards points on advertising costs with The New Business Gold Rewards Card from American Express OPEN. Designed to earn Membership Rewards® points faster:
• 3X points on airfare
• 2X points on advertising, gas, shipping
• 1X points on everything else
• For a limited time, 50K bonus points when you spend $10K your first 5 months
LEARN MORE AND APPLY |
  - South Korean researchers tout cloning 8 coyotes
Researchers at South Korea-based Sooam Biotech Research Foundation led by Hwang Woo-suk announced Monday that they have cloned eight coyotes as part of the organization's efforts to clone different species of animals. Gyeonggi Province officials said the province will raise the cloned specimens that will later be donated to zoos. Google/The Associated Press (10/17)  - Experts ID new technique to diagnose cancer mutations
The use of mutant enrichment with 3-foot-modified oligonucleotides showed significant concentration- and thermodynamics-dependent sensitivities in detecting cancer mutations in medical specimens, a study found. Experts also found that MEMO was able to block normal allele extension and enable mutated allele extension. The findings suggest that MEMO is a simple and highly sensitive technique for detecting cancer mutations, Korean researchers reported in The Journal of Molecular Diagnostics. PhysiciansBriefing.com/HealthDay News (10/14)      - Researchers use DNA sequencing method to detect blood pathogens
Use of a DNA sequencing method called peptide nucleic acid fluorescence in-situ hybridization in ICU patients with enterococcus or streptococcus bloodstream infections reduced their mortality rate by nearly 50% and cut mortality from yeast infections by 86%, according to a study conducted by researchers at the University of Arizona. The method also led to reductions in health care costs by about $5 million annually, the researchers said. BioOptics World (10/13)  | LET’S GO DESIGN: Episode #5
In this episode of SolidWorks’ interactive web series, Jeremy moves closer to the final design of our Hot Rod Baby Buggy and also hot-wires the golf cart motor to show how the aluminum tracks perform flawlessly. Watch at LetsGoDesign.tv. |
 - NICE declines to endorse Bristol's Yervoy for NHS coverage
The U.K. National Institute for Health and Clinical Excellence advised against National Health Service use of Bristol-Myers Squibb's Yervoy, citing the melanoma drug's high cost and unclear long-term benefit. "We need to be sure that new treatments provide sufficient benefits to patients to justify the significant cost the NHS is being asked to pay," said NICE CEO Andrew Dillon. The draft guidance is subject to consultation. Reuters (10/14)  | FREE TRIAL – Thomson Reuters Cortellis™ Pipeline Intelligence
Discover new opportunities in drug development and licensing faster. Cortellis gives you an innovative way of finding and acting on drug pipelines, deals, patents, companies, breaking industry news, and conference coverage in one source, intuitively presented.
Click here to see if you qualify for a free trial! |
 | | | Most Popular Headlines from Last Week Results based on number of times each story was clicked by readers. |
- DuPont's Kullman: Biotech farming needs to be tailored to local needs
DuPont Chairwoman and CEO Ellen Kullman said biotech seeds will help small-scale farmers in Africa and other in-need areas to produce food, but application of this technology needs to be customized to local needs. "At DuPont, we are under no illusion that laboratory science can drive food security on its own," Kullman said. Her remarks follow philanthropist Howard G. Buffett's warning that use of biotech seeds and other methods can worsen African growers' problems. Courier-Post (Camden-Cherry Hill, N.J.) (10/15)  | Enterprise Resource Planning automates many aspects of an organization's operations, cascading across traditional boundaries of operations, finance, manufacturing and more. As such, changes in the ERP market can cause a ripple effect in your business. Get ahead of the changing tide and trends by downloading this free whitepaper. |
 | Hot Topics | | | | Top five news stories selected by BIO SmartBrief readers in the past week. - Results based on number of times each story was clicked by readers.
| Industrial & Environmental | | | | - New JV to market Italian cellulosic-ethanol technology
Gruppo Mossi and Ghisolfi (M&G), which is developing the world's first commercial-scale cellulosic ethanol plant in Crescentino, Italy, has formed a joint venture with TPG Capital and TPG Biotech to license technology that would be used at the facility. The newly created Beta Renewables will market M&G's Proesa technology, which converts celulosic biomass into ethanol and renewable chemicals. Proesa is feedstock-flexible and doesn't require additional chemicals, said Dennis Leong, M&G's executive vice president of marketing and business development. Biofuels-News.com (U.K.) (10/14) | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is saving 2,700 companies nationwide on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot, Business Wire are just a few of the industry leading providers that offer special pricing through this members only program. Learn more or enroll here.
| SmartQuote | | | |  | Words ought to be a little wild for they are the assaults of thought on the unthinking."
--John Maynard Keynes,
British economist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Friday, October 14, 2011
- Thursday, October 13, 2011
- Wednesday, October 12, 2011
- Tuesday, October 11, 2011
- Monday, October 10, 2011
| | | Lead Editor: Adam Gaub
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment